Navidea Biopharmaceuticals, Inc. NAVB today announced that
data from its Lymphoseek^® (technetium Tc 99m tilmanocept) studies in breast
cancer and melanoma are being presented during the Radiological Society of
North America Conference (RSNA) in Chicago and the CTRC-AACR San Antonio
Breast Cancer Symposium in San Antonio, Texas.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: News
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in